This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

IPISC Announces IP Insurance For The Biotechnology/Pharma Industry









LOUISVILLE, Ky., Nov. 14, 2013 /PRNewswire/ -- As owners of intellectual property (IP), predominantly patents, the Biotechnology industry is particularly susceptible to others infringing their patent rights, as well others charging them with IP infringement for the products they are developing, which may have similar or even unrelated IP rights.



(Logo: http://photos.prnewswire.com/prnh/20130716/CL46586LOGO )

The Biotechnology industry ranks second, only behind the consumer products industry in the number of patent cases filed from 1995-2012. Given the rise in non-practicing entity (NPE)-generated IP litigation, the Biotech industry has not been spared, as NPEs, more times than not, have successfully fared through IP litigation against practicing entities in this industry.

Intellectual Property Insurance Services Corporation's ( IPISC) president, Robert Fletcher, reminds, "No company or industry sector is immune to patent infringement. The Biotech industry in particular is replete with innovative know-how, which can easily be accredited to rapidly, evolving technology. Biotech companies continue to invest heavily in new product development, while significantly relying upon the value and importance of IP and their ability to protect it."

IP insurance is the solution. It provides the funds to successfully litigate through an IP lawsuit. Only IPISC has been able to offer the market a full scope of IP-specific coverages including Defense, Abatement, Multi-Peril and Unauthorized Disclosure policies on a worldwide basis. IPISC has helped ensure that the funds and the litigation support have been available for the policy holder to get through the litigation process.

For further information, please contact Janet Zahnd, Sales/Marketing Manager, at jzahnd@patentinsurance.com, 502-855-5314, www.patentinsurance.com.

About IPISC

IPISC has remained the market leader and expert in the dynamic field of Intellectual Property (IP) Insurance by using advanced strategies to manage IP risks and protect the value of our clients' IP. We are committed to providing first-rate underwriting, insurance products and litigation management services.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs